Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: September 27, 2022

Details for Patent: 8,511,581

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Summary for Patent: 8,511,581
Title:Fluid droplet production apparatus and method
Abstract: A fluid dispersion device comprises a substrate having an outer section and an inner section, said inner section of the substrate having an aperture, a dispersion element positioned at said aperture of said substrate, and an actuator arranged to coaxially surround said aperture of said substrate, wherein the outer edge of said inner section of said substrate is coupled to said outer section of said substrate by a plurality of resilient members.
Inventor(s): Urich; Markus (Munich, DE), Hyde; Samuel Charles William (Cambridge, GB), Pollock; Neil (Royston, GB), Sant; Andrew Jonathan (Cambridge, GB)
Assignee: PARI Pharma GmbH (Starnberg, DE)
Application Number:13/042,980
Patent Claim Types:
see list of patent claims

Drugs Protected by US Patent 8,511,581

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sunovion Resp LONHALA MAGNAIR KIT glycopyrrolate SOLUTION;INHALATION 208437-001 Dec 5, 2017 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,511,581

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
02016972Aug 2, 2002

International Family Members for US Patent 8,511,581

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 463304 See Plans and Pricing
Germany 60235883 See Plans and Pricing
European Patent Office 1386672 See Plans and Pricing
World Intellectual Property Organization (WIPO) 2004014569 See Plans and Pricing
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.